▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Stock News & Analysis

Thoughtful person looking at graphs on a tablet computer

Does Billionaire David Tepper Know Something Wall Street Doesn't? He Sold 100% of Appaloosa's Broadcom Stock and Piled Into This High-Profile Artificial Intelligence (AI) Chipmaker Instead

Editors’ Picks

A person puts coins in glass jars that sprout plants, illustrating the power of compound returns and passive income.

Aug 21, 2025 by Daniel Foelber

The Vanguard S&P 500 ETF Yields Just 1.2%. Here Are 3 Better ETFs for Boosting Your Passive Income.

Income investors may want to branch out beyond S&P 500 ETFs to boost their passive income stream.

growing money savings growth investing

Aug 21, 2025 by John Ballard

2 Growth Stocks to Buy and Hold Forever

These top performers can help you build wealth.

22_08_08 A balance showing risk and reward _MF Dload

Aug 21, 2025 by Reuben Gregg Brewer

Is Archer Aviation the Smartest Investment You Can Make Today?

The electric air taxi specialist is moving steadily toward liftoff, but after its massive stock rally over the past year, is it still worth buying?

Recent Articles

Getty - insurance policy and glasses (1)

Aug 21, 2025 by Adam Spatacco

As Buffett as it Gets: 7 Reasons Why Berkshire Hathaway Just Bought This Monster Health Insurance Stock

Berkshire's latest 13F is out, and one savvy new position sticks out among the pack.

A person puts coins in glass jars that sprout plants, illustrating the power of compound returns and passive income.

Aug 21, 2025 by Daniel Foelber

The Vanguard S&P 500 ETF Yields Just 1.2%. Here Are 3 Better ETFs for Boosting Your Passive Income.

Income investors may want to branch out beyond S&P 500 ETFs to boost their passive income stream.

Social Security

Aug 21, 2025 by Dana George

5 Social Security Myths That Could Hurt You

Social Security plays such an essential role in most Americans' lives that it's natural for rumors and myths to pop up. However, the following myths could cost you money and needless sleepless nights.

Aug 21, 2025 by Kristi Waterworth

Slocum Gordon Exits Stake in Kimberly-Clark Worth Nearly $3 Million

Aug 21, 2025 by Motley Fool Markets Team

Nordson Q3 Sales Jump 12 Percent

Stock traders 2025

Aug 21, 2025 by Matt Frankel and Tyler Crowe

These 2 Stocks Are at 52-Week Highs, but They Could Still Go Higher

Not all stocks are expensive just because they reach new peaks.

Aug 21, 2025 by Motley Fool Markets Team

Axil Brands Reports 4% Sales Drop in Q4

Aug 21, 2025 by Motley Fool Markets Team

SelectQuote Revenue Soars 55 Percent

Aug 21, 2025 by Motley Fool Markets Team

Walmart Q2 Sales Rise 5 Percent

Aug 21, 2025 by Motley Fool Markets Team

Navios Maritime Partners Q2 Revenue Up

Bitcoin symbol on top of gold coins

Aug 21, 2025 by Anders Bylund

If You'd Invested $1,000 in Bitcoin (BTC) 5 Years Ago, Here's How Much You'd Have Today

What would $1,000 in Bitcoin be worth today? Compare the exact five-year totals for Bitcoin against the Vanguard VOO and Invesco QQQ funds.

Aug 21, 2025 by Motley Fool Markets Team

BOS Reports 36 Percent Revenue Jump

Aug 21, 2025 by Motley Fool Markets Team

ScanSource Posts 9% Revenue Gain in Q4

Aug 21, 2025 by Motley Fool Markets Team

Canadian Solar Posts $1.7 Billion Sales

Aug 21, 2025 by Motley Fool Markets Team

OSI Systems Posts 5% Revenue Gain in Q4

growing money savings growth investing

Aug 21, 2025 by John Ballard

2 Growth Stocks to Buy and Hold Forever

These top performers can help you build wealth.

Aug 21, 2025 by Motley Fool Markets Team

Full Truck Alliance Earnings Surge

Aug 21, 2025 by Motley Fool Markets Team

VNET Group Q2 Revenue Jumps 22 Percent

Aug 21, 2025 by Lee Samaha

Sender Buys Into the Turnaround Story at Kenvue

Patient self-administering a shot

Aug 21, 2025 by Prosper Junior Bakiny

The FDA Just Approved a New Use for Wegovy, and Novo Nordisk Stock is Climbing. Here's What Investors Need to Know

The famous medicine continues its impressive march forward.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services